Ypsomed creates new jobs and invests in Solothurn facility

Press Releases Ypsomed Group

Burgdorf – A significant part of this extension is yet another major project for long-standing partner Sanofi.

Read more...

Ypsomed is investing in the future

Press Releases Ypsomed Group

Burgdorf – The Ypsomed Group will also be securing its position as a technology leader in the field of injection and infusion systems well into the future.

Read more...

Ypsomed semi-annual results 2015/16: report and press release

Press Releases Ypsomed Group

Burgdorf – Ypsomed increases EBIT margin in double digits and raises the forecast for the business year 2015/16 clearly.

Read more...

Ypsomed signs master agreement for range of injection systems

Press Releases Ypsomed Group

Burgdorf – Hanmi Pharmaceutical Co., Ltd. has three biotechnology proteins in its project portfolio that are in various stages of development and approval. Ypsomed signs comprehensive master agreement with the South Korean Hanmi Pharmaceutical Co., Ltd. for pen systems and autoinjectors for three long-acting biologics.

Read more...

Ypsomed doubles dividends to shareholders

Press Releases Ypsomed Group

Burgdorf – For the 2014/15 fiscal year, a dividend of CHF 0.60 per share, exempt from withholding tax, will be paid to shareholders from capital reserves.

Read more...